Skip to content
10-Q

Quarterly Report

PHIBRO ANIMAL HEALTH CORP PAHC

0001104659-26-056280

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2026 · Mar 31, 2026 41.04M sh
Shares Diluted Q3 2026 · Mar 31, 2026 40.96M sh
Shares Diluted Q3 2026 · Mar 31, 2025 40.71M sh
Shares Diluted Q3 2026 · Mar 31, 2025 40.67M sh
Dividends Paid Q3 2026 · Mar 31, 2026 $14.6M
Dividends Paid Q3 2026 · Mar 31, 2025 $14.59M
Capex Q3 2026 · Mar 31, 2026 $40.22M
Capex Q3 2026 · Mar 31, 2025 $25.15M
Operating Cash Flow Q3 2026 · Mar 31, 2026 $44.86M
Operating Cash Flow Q3 2026 · Mar 31, 2025 $58.85M
Long Term Debt Q3 2026 · Mar 31, 2026 $597.69M
Long Term Debt Q3 2026 · Jun 30, 2025 $615.44M
Short Term Investments Q3 2026 · Mar 31, 2026 $22.52M
Short Term Investments Q3 2026 · Jun 30, 2025 $9M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $54.93M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $68.04M
Stockholders Equity Q3 2026 · Mar 31, 2026 $361.83M
Stockholders Equity Q3 2026 · Jun 30, 2025 $285.68M
Current Liabilities Q3 2026 · Mar 31, 2026 $281.87M
Current Liabilities Q3 2026 · Jun 30, 2025 $293.47M
Total Liabilities Q3 2026 · Mar 31, 2026 $1.08B
Total Liabilities Q3 2026 · Jun 30, 2025 $1.08B
Current Assets Q3 2026 · Mar 31, 2026 $894.07M
Current Assets Q3 2026 · Jun 30, 2025 $810.61M
Total Assets Q3 2026 · Mar 31, 2026 $1.45B
Total Assets Q3 2026 · Jun 30, 2025 $1.36B
Eps Diluted Q3 2026 · Mar 31, 2026 $0.59
Eps Diluted Q3 2026 · Mar 31, 2026 $1.90
Eps Diluted Q3 2026 · Mar 31, 2025 $0.51
Eps Diluted Q3 2026 · Mar 31, 2025 $0.76
Eps Basic Q3 2026 · Mar 31, 2026 $0.59
Eps Basic Q3 2026 · Mar 31, 2026 $1.92
Eps Basic Q3 2026 · Mar 31, 2025 $0.52
Eps Basic Q3 2026 · Mar 31, 2025 $0.77
Sga Expense Q3 2026 · Mar 31, 2026 $81.02M
Sga Expense Q3 2026 · Mar 31, 2026 $231.88M
Sga Expense Q3 2026 · Mar 31, 2025 $71.05M
Sga Expense Q3 2026 · Mar 31, 2025 $213.19M
Net Income Q3 2026 · Mar 31, 2026 $24.02M
Net Income Q3 2026 · Mar 31, 2026 $78.01M
Net Income Q3 2026 · Mar 31, 2025 $20.88M
Net Income Q3 2026 · Mar 31, 2025 $31.04M
Operating Income Q3 2026 · Mar 31, 2026 $44.65M
Operating Income Q3 2026 · Mar 31, 2026 $146.24M
Operating Income Q3 2026 · Mar 31, 2025 $33.52M
Operating Income Q3 2026 · Mar 31, 2025 $76.75M
Gross Profit Q3 2026 · Mar 31, 2026 $125.68M
Gross Profit Q3 2026 · Mar 31, 2026 $378.11M
Gross Profit Q3 2026 · Mar 31, 2025 $104.57M
Gross Profit Q3 2026 · Mar 31, 2025 $289.93M
Cost Of Revenue Q3 2026 · Mar 31, 2026 $257.87M
Cost Of Revenue Q3 2026 · Mar 31, 2026 $743.23M
Cost Of Revenue Q3 2026 · Mar 31, 2025 $243.26M
Cost Of Revenue Q3 2026 · Mar 31, 2025 $627.59M
Revenue Q3 2026 · Mar 31, 2026 $383.54M
Revenue Q3 2026 · Mar 31, 2026 $1.12B
Revenue Q3 2026 · Mar 31, 2025 $347.83M
Revenue Q3 2026 · Mar 31, 2025 $917.52M